Category: Journal

Posted on

JHC2023v7i1s6

Original Contribution

Stromal Expression of CD10 in invasive Ductal Carcinoma and its relationship
with ER, PR and HER2-neu Status

1.*Dr. Farah Imrana, MD (Histopathology), Assistant Professor, BIHS General Hospital. 125/1Darus
Salam, Mirpur, Dhaka.. farahdr02@gmail.com
2. Dr. Md. Shahriar Mamun, Assistant Professor (cc), Department of Pathology, Satkhira Medical College.
3. Dr. SM Moshadeq Hossain, Assistant Professor, Pathology, Rajshahi Medical College.
4. Dr. Alimul Hassan, Clinical Pathologist, Rangpur Medical College Hospital.

*For correspondence

Abstract
Background: Ductal carcinoma is a common type of breast cancer that starts in cells of milk ducts
and can enhance the risk of developing invasive breast cancer in the long run. The study aimed to
evaluate the stromal expression of CD10 in Invasive Ductal Carcinoma and its relationship with
ER, PR, and HER-2 status.
Methods: This cross-sectional study was carried out in the Department of Pathology, Rajshahi
Medical College, Rajshahi, from July 2017 to December 2018, to evaluate the expression of
stromal CD10 in invasive breast carcinoma and to correlate with ER, PR, HER 2/neu status in
mastectomy or lumpectomy specimen. A total of 50 cases of mastectomy or lumpectomy
specimens will be taken that were received in the Department. Samples were selected by the
purposive sampling technique.
Results: In the present study, out of total 50 cases, most of the study subjects that is 17 (34%)
belonged to the age group of 51-60 years. Estrogen receptor were positive in 29(58.0%) cases,
progesterone receptor was positive in 16(32.0%) cases. The association between estrogen receptor
status with stromal CD10, all the 16 (100.0%) CD 10 strong positive cases were negative for
estrogen receptor. In CD10 negative group, almost all 28 (96.6%) cases were positive for estrogen
receptor. The difference was statistically significant (p<0.05).
Conclusion: Substantial knowledge regarding stromal contribution to cancer progression could
help researchers to identify particular signals which could lead to the revelation of new therapeutic
targets in the future.

[Journal of Histopathology and Cytopathology, 2023 Jan; 7 (1):36-44]
Keywords: Ductal carcinoma, CD10, Estrogen receptor, Progesterone receptor, Her-2, Invasive

Full Article

PDF

 

Posted on

JHC 2023 January v7 i1 s5

Original Contribution

Evaluation of Stromal CD10 Expression and its Correlation with other Clinicopathological Factors in Invasive Breast Carcinoma

1.*Dr. Farah Imrana, MD (Histopathology), Assistant Professor, BIHS General Hospital. 125/1Darus
Salam, Mirpur, Dhaka. farahdr02@gmail.com
2. Dr. Md. Shahriar Mamun, Assistant Professor (cc), Department of Pathology, Satkhira Medical College.
3. Dr. SM Moshadeq Hossain, Assistant Professor, Pathology, Rajshahi Medical College.
4. Dr. Alimul Hassan, Lecturer, Department of Pathology, Pabna Medical College.
*For correspondence

Abstract
Background: Expression of stromal CD10 was considerably remarked with metastasis of lymph
node and higher tumor grade. CD10 is a useful independent prognostic indicator which is
necessary to include in routine histopathology report
Objective: The intent of the study was to investigate the expression of stromal CD10 in invasive
breast carcinoma.
Methods: This cross sectional study was carried out in the department of Pathology, Rajshahi
Medical College, Rajshahi, during July 2017 to December 2018, to evaluate the expression of
stromal CD10 in invasive breast carcinoma and to correlate with ER, PR status in mastectomy
specimen. A total of 50 cases of mastectomy or lumpectomy specimens will be taken that are
received in the Department. Samples were selected by the purposive sampling technique.
Result: In the present study, out of 50 cases stromal CD 10 was found to be strong positive in
13(36.1%), weak positive in 9(25%) and negative in 14(38.9%) cases. Regarding the association
between tumor grade with stromal CD10 it was observed that 9 (56.3%) out of total 16 CD 10
strong positive cases, 3 (60.0%) out of five CD10 weak positive and 26 (89.7%) out of 29 CD 10
negative were grade I tumor. Seven (43.8%) were grade II tumor in the strong positive group, 2
(40.0%) in weak positive group and none in negative group. In this series it was observed that
maximum 38 (76.0%) cases were grade II tumors followed by 09 (18.0%) cases were grade I and
03 (6.0%) cases were grade III tumor. The difference was statistically significant (p<0.05) between
tumor grade with stromal CD 10 expression.
Conclusion: This study was undertaken to detect the expression of stromal CD10 in invasive
breast carcinoma in mastectomy specimen. Tumor grade was significantly (p<0.05) associated with
stromal CD 10.

[Journal of Histopathology and Cytopathology, 2023 Jan; 7 (1):27-35]
Keywords: Stromal, CD10, Carcinoma

Full article

PDF

Posted on

JHC 2023 January v7 i1 s4

Original Contribution

Role of FNAC and Core Needle Biopsy in the Diagnosis of Breast Lesions

1.*Dr. Anindita Sarkar, MD (Pathology), Assistant Professor (C.C), Pathology Department, Rajshahi Medical
College. abantica.16@gmail.com.
2. Prof. Dr. S. M. Asafudullah, MD (Pathology), Professor and Head of Department of Pathology, Rajshahi Medical
College.
3. Dr. Khadiza Khanam, MD (Pathology), Professor, Pathology Department, Rajshahi Medical College.
4. Dr. Rukhshana Akhter Jahan, MD (Pathology), Associate Professor, Pathology Department, Rajshahi Medical
College.
5. Dr. Tanshina Afrin, MD (Pathology), Assistant Professor (C.C), Pathology Department, Rajshahi Medical College.
6. Dr. Rebeka Sultana, MD (Pathology), Consultant, Islami Bank Hospital, Rajshahi.
*For correspondence

Abstract
Background: Though excision biopsy of breast lump is considered to be the gold standard method
for diagnosis, there should be an improved and definitive method for establishing an accurate
diagnosis of breast lesions prior to surgery. This study was carried out to evaluate the efficacy and
diagnostic performance of fine needle aspiration cytology (FNAC) and core needle biopsy (CNB)
in the preoperative assessment of breast lesions.
Methods: This cross-sectional study was conducted in the private diagnostic center in Rajshahi,
Bangladesh over a period of one year from January 2022 to December 2022.A total of 60 cases
were subjected to both FNAC and CNB from the same breast lesions included in this study.
Result: The age range of total 60 patients was 22-85 years with mean age of 42.18 ±SD 12.15
years. 38 patients had benign lesions and 22 had malignant tumors. Sensitivity, specificity, positive
predictive value, negative predictive value, and diagnostic accuracy for FNAC were 89.4%, 100%,
100%, 84.6%, and 93.3%, respectively in diagnosing carcinoma. CNB had sensitivity, specificity,
positive predictive value, negative predictive value, and diagnostic accuracy of 94.7%, 100%,
100%, 91.6% and 91.6% respectively. Both FNAC and CNB showed statistically significant
association.
Conclusion: Taking into account the benefits and outcomes, combined approach of FNAC and
CNB can provide accurate preoperative diagnosis of breast lesions and provide important
information for appropriate treatment

[Journal of Histopathology and Cytopathology, 2023 Jan; 7 (1):21-26]
Keywords: FNAC, Core needle biopsy (CNB), Breast lesion

Full article

PDF